Stockreport

Catalyst Pharmaceuticals: Revenue Growth Lagging Expense Growth (Rating Downgrade) [Seeking Alpha]

Catalyst Pharmaceuticals, Inc.  (CPRX) 
Last catalyst pharmaceuticals, inc. earnings: 3/16 05:26 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.catalystpharma.com
PDF Its stock price is no longer depressed, and its guidance for 2024 is unremarkable, leading to a downgrading to a "Hold". Acquisition of commercial rights to FYCOMPA h [Read more]